nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylsalicylic acid—TP53—brain cancer	0.433	0.667	CbGaD
Acetylsalicylic acid—CYP2C9—brain cancer	0.216	0.333	CbGaD
Acetylsalicylic acid—PTGS2—Etoposide—brain cancer	0.0161	0.376	CbGbCtD
Acetylsalicylic acid—PTGS1—Etoposide—brain cancer	0.0136	0.317	CbGbCtD
Acetylsalicylic acid—CYP2C8—Etoposide—brain cancer	0.00787	0.183	CbGbCtD
Acetylsalicylic acid—TP53—skull—brain cancer	0.00625	0.0732	CbGeAlD
Acetylsalicylic acid—ABCB1—Etoposide—brain cancer	0.00532	0.124	CbGbCtD
Acetylsalicylic acid—Haemorrhagic disorder—Procarbazine—brain cancer	0.00453	0.06	CcSEcCtD
Acetylsalicylic acid—HSPA5—pineal body—brain cancer	0.00437	0.0512	CbGeAlD
Acetylsalicylic acid—HSPA5—ganglion—brain cancer	0.00313	0.0367	CbGeAlD
Acetylsalicylic acid—TP53—endothelium—brain cancer	0.0028	0.0329	CbGeAlD
Acetylsalicylic acid—NFKBIA—endothelium—brain cancer	0.00276	0.0323	CbGeAlD
Acetylsalicylic acid—TP53—blood vessel—brain cancer	0.00258	0.0303	CbGeAlD
Acetylsalicylic acid—NFKBIA—blood vessel—brain cancer	0.00254	0.0298	CbGeAlD
Acetylsalicylic acid—TP53—hindbrain—brain cancer	0.00247	0.0289	CbGeAlD
Acetylsalicylic acid—NFKBIA—hindbrain—brain cancer	0.00243	0.0284	CbGeAlD
Acetylsalicylic acid—HSPA5—hindbrain—brain cancer	0.00238	0.0278	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Lomustine—brain cancer	0.00234	0.0309	CcSEcCtD
Acetylsalicylic acid—Gastric irritation—Hydroxyurea—brain cancer	0.00229	0.0303	CcSEcCtD
Acetylsalicylic acid—Contusion—Lomustine—brain cancer	0.00207	0.0274	CcSEcCtD
Acetylsalicylic acid—TP53—Podofilox—Etoposide—brain cancer	0.00197	0.569	CbGdCrCtD
Acetylsalicylic acid—Clotting—Temozolomide—brain cancer	0.00194	0.0257	CcSEcCtD
Acetylsalicylic acid—Epigastric discomfort—Hydroxyurea—brain cancer	0.00169	0.0223	CcSEcCtD
Acetylsalicylic acid—Haematemesis—Procarbazine—brain cancer	0.00165	0.0218	CcSEcCtD
Acetylsalicylic acid—NFKBIA—Podofilox—Etoposide—brain cancer	0.00149	0.431	CbGdCrCtD
Acetylsalicylic acid—Eruption—Hydroxyurea—brain cancer	0.00144	0.0191	CcSEcCtD
Acetylsalicylic acid—TP53—brainstem—brain cancer	0.00141	0.0166	CbGeAlD
Acetylsalicylic acid—Metabolic acidosis—Etoposide—brain cancer	0.0014	0.0186	CcSEcCtD
Acetylsalicylic acid—NFKBIA—brainstem—brain cancer	0.00139	0.0163	CbGeAlD
Acetylsalicylic acid—HSPA5—brainstem—brain cancer	0.00136	0.016	CbGeAlD
Acetylsalicylic acid—TP53—telencephalon—brain cancer	0.00125	0.0147	CbGeAlD
Acetylsalicylic acid—NFKBIA—telencephalon—brain cancer	0.00123	0.0145	CbGeAlD
Acetylsalicylic acid—HSPA5—telencephalon—brain cancer	0.00121	0.0142	CbGeAlD
Acetylsalicylic acid—Hearing impaired—Procarbazine—brain cancer	0.0012	0.0159	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Hydroxyurea—brain cancer	0.00115	0.0152	CcSEcCtD
Acetylsalicylic acid—Melaena—Procarbazine—brain cancer	0.00112	0.0148	CcSEcCtD
Acetylsalicylic acid—Coma—Procarbazine—brain cancer	0.00105	0.0139	CcSEcCtD
Acetylsalicylic acid—TP53—gonad—brain cancer	0.00105	0.0123	CbGeAlD
Acetylsalicylic acid—NFKBIA—gonad—brain cancer	0.00103	0.0121	CbGeAlD
Acetylsalicylic acid—RPS6KA3—telencephalon—brain cancer	0.00103	0.0121	CbGeAlD
Acetylsalicylic acid—TP53—pituitary gland—brain cancer	0.00102	0.012	CbGeAlD
Acetylsalicylic acid—HSPA5—gonad—brain cancer	0.00101	0.0118	CbGeAlD
Acetylsalicylic acid—NFKBIA—pituitary gland—brain cancer	0.001	0.0118	CbGeAlD
Acetylsalicylic acid—HSPA5—pituitary gland—brain cancer	0.000984	0.0115	CbGeAlD
Acetylsalicylic acid—NFKBIA—medulla oblongata—brain cancer	0.000969	0.0114	CbGeAlD
Acetylsalicylic acid—HSPA5—medulla oblongata—brain cancer	0.000949	0.0111	CbGeAlD
Acetylsalicylic acid—Ulcer—Hydroxyurea—brain cancer	0.000937	0.0124	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Procarbazine—brain cancer	0.00093	0.0123	CcSEcCtD
Acetylsalicylic acid—Deafness—Procarbazine—brain cancer	0.00093	0.0123	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Carmustine—brain cancer	0.000928	0.0123	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Lomustine—brain cancer	0.000911	0.0121	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Lomustine—brain cancer	0.000906	0.012	CcSEcCtD
Acetylsalicylic acid—Hepatotoxicity—Temozolomide—brain cancer	0.000897	0.0119	CcSEcCtD
Acetylsalicylic acid—Coagulopathy—Temozolomide—brain cancer	0.00089	0.0118	CcSEcCtD
Acetylsalicylic acid—NFKBIA—midbrain—brain cancer	0.000886	0.0104	CbGeAlD
Acetylsalicylic acid—TP53—spinal cord—brain cancer	0.000879	0.0103	CbGeAlD
Acetylsalicylic acid—HSPA5—midbrain—brain cancer	0.000868	0.0102	CbGeAlD
Acetylsalicylic acid—NFKBIA—spinal cord—brain cancer	0.000864	0.0101	CbGeAlD
Acetylsalicylic acid—Purpura—Procarbazine—brain cancer	0.000863	0.0114	CcSEcCtD
Acetylsalicylic acid—HSPA5—spinal cord—brain cancer	0.000847	0.00992	CbGeAlD
Acetylsalicylic acid—RPS6KA3—pituitary gland—brain cancer	0.000838	0.00982	CbGeAlD
Acetylsalicylic acid—RPS6KA3—medulla oblongata—brain cancer	0.000809	0.00948	CbGeAlD
Acetylsalicylic acid—TP53—endocrine gland—brain cancer	0.000791	0.00927	CbGeAlD
Acetylsalicylic acid—TP53—head—brain cancer	0.000781	0.00915	CbGeAlD
Acetylsalicylic acid—NFKBIA—endocrine gland—brain cancer	0.000778	0.00912	CbGeAlD
Acetylsalicylic acid—Mefenamic acid—CYP2C9—brain cancer	0.00077	0.555	CrCbGaD
Acetylsalicylic acid—NFKBIA—head—brain cancer	0.000768	0.00901	CbGeAlD
Acetylsalicylic acid—HSPA5—endocrine gland—brain cancer	0.000762	0.00893	CbGeAlD
Acetylsalicylic acid—IKBKB—telencephalon—brain cancer	0.00076	0.00891	CbGeAlD
Acetylsalicylic acid—HSPA5—head—brain cancer	0.000752	0.00882	CbGeAlD
Acetylsalicylic acid—RPS6KA3—midbrain—brain cancer	0.000739	0.00866	CbGeAlD
Acetylsalicylic acid—Hearing impaired—Temozolomide—brain cancer	0.000728	0.00963	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—spinal cord—brain cancer	0.000721	0.00845	CbGeAlD
Acetylsalicylic acid—Hepatotoxicity—Etoposide—brain cancer	0.000718	0.0095	CcSEcCtD
Acetylsalicylic acid—TP53—central nervous system—brain cancer	0.000713	0.00836	CbGeAlD
Acetylsalicylic acid—Leukopenia—Lomustine—brain cancer	0.000706	0.00934	CcSEcCtD
Acetylsalicylic acid—Respiratory failure—Temozolomide—brain cancer	0.000705	0.00933	CcSEcCtD
Acetylsalicylic acid—NFKBIA—central nervous system—brain cancer	0.000701	0.00822	CbGeAlD
Acetylsalicylic acid—TP53—cerebellum—brain cancer	0.000697	0.00817	CbGeAlD
Acetylsalicylic acid—HSPA5—central nervous system—brain cancer	0.000687	0.00805	CbGeAlD
Acetylsalicylic acid—NFKBIA—cerebellum—brain cancer	0.000685	0.00803	CbGeAlD
Acetylsalicylic acid—EDNRA—pituitary gland—brain cancer	0.000681	0.00799	CbGeAlD
Acetylsalicylic acid—HSPA5—cerebellum—brain cancer	0.000671	0.00787	CbGeAlD
Acetylsalicylic acid—EDNRA—medulla oblongata—brain cancer	0.000657	0.00771	CbGeAlD
Acetylsalicylic acid—PTGS1—ganglion—brain cancer	0.000655	0.00768	CbGeAlD
Acetylsalicylic acid—Coma—Carmustine—brain cancer	0.000655	0.00867	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—endocrine gland—brain cancer	0.000649	0.00761	CbGeAlD
Acetylsalicylic acid—Drowsiness—Procarbazine—brain cancer	0.000641	0.00848	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—head—brain cancer	0.000641	0.00751	CbGeAlD
Acetylsalicylic acid—IKBKB—gonad—brain cancer	0.000634	0.00743	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Lomustine—brain cancer	0.00063	0.00834	CcSEcCtD
Acetylsalicylic acid—Chest discomfort—Etoposide—brain cancer	0.000626	0.00829	CcSEcCtD
Acetylsalicylic acid—IKBKB—pituitary gland—brain cancer	0.000619	0.00725	CbGeAlD
Acetylsalicylic acid—Salicylic acid—CYP2C9—brain cancer	0.000618	0.445	CrCbGaD
Acetylsalicylic acid—Sweating—Procarbazine—brain cancer	0.000614	0.00813	CcSEcCtD
Acetylsalicylic acid—EDNRA—midbrain—brain cancer	0.000601	0.00704	CbGeAlD
Acetylsalicylic acid—Diabetes mellitus—Carmustine—brain cancer	0.000598	0.00792	CcSEcCtD
Acetylsalicylic acid—Ulcer—Etoposide—brain cancer	0.000586	0.00776	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—central nervous system—brain cancer	0.000585	0.00686	CbGeAlD
Acetylsalicylic acid—Haemoglobin—Procarbazine—brain cancer	0.000578	0.00765	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Procarbazine—brain cancer	0.000575	0.00761	CcSEcCtD
Acetylsalicylic acid—RPS6KA3—cerebellum—brain cancer	0.000572	0.0067	CbGeAlD
Acetylsalicylic acid—TP53—brain—brain cancer	0.000566	0.00663	CbGeAlD
Acetylsalicylic acid—PTGS1—endothelium—brain cancer	0.000565	0.00662	CbGeAlD
Acetylsalicylic acid—Deafness—Temozolomide—brain cancer	0.000562	0.00744	CcSEcCtD
Acetylsalicylic acid—Vascular purpura—Temozolomide—brain cancer	0.000562	0.00744	CcSEcCtD
Acetylsalicylic acid—NFKBIA—brain—brain cancer	0.000557	0.00653	CbGeAlD
Acetylsalicylic acid—HSPA5—brain—brain cancer	0.000545	0.00639	CbGeAlD
Acetylsalicylic acid—PTGS2—endothelium—brain cancer	0.00054	0.00633	CbGeAlD
Acetylsalicylic acid—Flushing—Procarbazine—brain cancer	0.000534	0.00707	CcSEcCtD
Acetylsalicylic acid—Thirst—Temozolomide—brain cancer	0.000528	0.00699	CcSEcCtD
Acetylsalicylic acid—Purpura—Temozolomide—brain cancer	0.000522	0.0069	CcSEcCtD
Acetylsalicylic acid—PTGS1—blood vessel—brain cancer	0.000521	0.00611	CbGeAlD
Acetylsalicylic acid—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00052	0.00689	CcSEcCtD
Acetylsalicylic acid—PTGS2—blood vessel—brain cancer	0.000498	0.00584	CbGeAlD
Acetylsalicylic acid—Drowsiness—Hydroxyurea—brain cancer	0.000496	0.00656	CcSEcCtD
Acetylsalicylic acid—IKBKB—endocrine gland—brain cancer	0.000479	0.00562	CbGeAlD
Acetylsalicylic acid—Hypokalaemia—Carmustine—brain cancer	0.000473	0.00627	CcSEcCtD
Acetylsalicylic acid—IKBKB—head—brain cancer	0.000473	0.00555	CbGeAlD
Acetylsalicylic acid—SLC22A7—endocrine gland—brain cancer	0.000465	0.00545	CbGeAlD
Acetylsalicylic acid—RPS6KA3—brain—brain cancer	0.000464	0.00544	CbGeAlD
Acetylsalicylic acid—Anaemia—Procarbazine—brain cancer	0.000463	0.00613	CcSEcCtD
Acetylsalicylic acid—Hypokalaemia—Temozolomide—brain cancer	0.000458	0.00606	CcSEcCtD
Acetylsalicylic acid—Syncope—Procarbazine—brain cancer	0.000449	0.00594	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Procarbazine—brain cancer	0.000448	0.00593	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Hydroxyurea—brain cancer	0.000447	0.00592	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Hydroxyurea—brain cancer	0.000445	0.00589	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Procarbazine—brain cancer	0.00044	0.00583	CcSEcCtD
Acetylsalicylic acid—Convulsion—Procarbazine—brain cancer	0.000434	0.00574	CcSEcCtD
Acetylsalicylic acid—Hypertension—Procarbazine—brain cancer	0.000432	0.00572	CcSEcCtD
Acetylsalicylic acid—IKBKB—central nervous system—brain cancer	0.000432	0.00506	CbGeAlD
Acetylsalicylic acid—Arthralgia—Procarbazine—brain cancer	0.000426	0.00564	CcSEcCtD
Acetylsalicylic acid—IKBKB—cerebellum—brain cancer	0.000422	0.00495	CbGeAlD
Acetylsalicylic acid—Confusional state—Procarbazine—brain cancer	0.000412	0.00545	CcSEcCtD
Acetylsalicylic acid—Vomiting—Lomustine—brain cancer	0.000409	0.00542	CcSEcCtD
Acetylsalicylic acid—Shock—Procarbazine—brain cancer	0.000402	0.00532	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Procarbazine—brain cancer	0.0004	0.0053	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Procarbazine—brain cancer	0.000399	0.00528	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Procarbazine—brain cancer	0.000395	0.00523	CcSEcCtD
Acetylsalicylic acid—Nausea—Lomustine—brain cancer	0.000382	0.00506	CcSEcCtD
Acetylsalicylic acid—EDNRA—brain—brain cancer	0.000378	0.00443	CbGeAlD
Acetylsalicylic acid—Somnolence—Procarbazine—brain cancer	0.000363	0.00481	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Carmustine—brain cancer	0.000362	0.00479	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Carmustine—brain cancer	0.00036	0.00476	CcSEcCtD
Acetylsalicylic acid—Anaemia—Hydroxyurea—brain cancer	0.000358	0.00474	CcSEcCtD
Acetylsalicylic acid—Haemoglobin—Temozolomide—brain cancer	0.00035	0.00463	CcSEcCtD
Acetylsalicylic acid—Haemorrhage—Temozolomide—brain cancer	0.000348	0.0046	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Hydroxyurea—brain cancer	0.000347	0.00459	CcSEcCtD
Acetylsalicylic acid—IKBKB—brain—brain cancer	0.000343	0.00402	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Procarbazine—brain cancer	0.000337	0.00446	CcSEcCtD
Acetylsalicylic acid—Convulsion—Hydroxyurea—brain cancer	0.000336	0.00444	CcSEcCtD
Acetylsalicylic acid—Flushing—Carmustine—brain cancer	0.000334	0.00442	CcSEcCtD
Acetylsalicylic acid—SLC22A7—brain—brain cancer	0.000333	0.0039	CbGeAlD
Acetylsalicylic acid—Urticaria—Procarbazine—brain cancer	0.000325	0.0043	CcSEcCtD
Acetylsalicylic acid—Tinnitus—Temozolomide—brain cancer	0.000324	0.00429	CcSEcCtD
Acetylsalicylic acid—Flushing—Temozolomide—brain cancer	0.000323	0.00427	CcSEcCtD
Acetylsalicylic acid—SLC22A6—brain—brain cancer	0.000321	0.00376	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Hydroxyurea—brain cancer	0.00031	0.0041	CcSEcCtD
Acetylsalicylic acid—ABCB1—blood vessel—brain cancer	0.000308	0.00361	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Procarbazine—brain cancer	0.000301	0.00399	CcSEcCtD
Acetylsalicylic acid—Anaemia—Carmustine—brain cancer	0.00029	0.00383	CcSEcCtD
Acetylsalicylic acid—Pruritus—Procarbazine—brain cancer	0.000289	0.00383	CcSEcCtD
Acetylsalicylic acid—Agitation—Carmustine—brain cancer	0.000288	0.00381	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Hydroxyurea—brain cancer	0.000282	0.00373	CcSEcCtD
Acetylsalicylic acid—Somnolence—Hydroxyurea—brain cancer	0.000281	0.00372	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Carmustine—brain cancer	0.00028	0.00371	CcSEcCtD
Acetylsalicylic acid—Anaemia—Temozolomide—brain cancer	0.00028	0.0037	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Procarbazine—brain cancer	0.00028	0.0037	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Hydroxyurea—brain cancer	0.000278	0.00369	CcSEcCtD
Acetylsalicylic acid—Agitation—Temozolomide—brain cancer	0.000278	0.00368	CcSEcCtD
Acetylsalicylic acid—Angioedema—Temozolomide—brain cancer	0.000277	0.00366	CcSEcCtD
Acetylsalicylic acid—Vertigo—Temozolomide—brain cancer	0.000272	0.0036	CcSEcCtD
Acetylsalicylic acid—Convulsion—Carmustine—brain cancer	0.000271	0.00359	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Temozolomide—brain cancer	0.000271	0.00359	CcSEcCtD
Acetylsalicylic acid—Hypertension—Carmustine—brain cancer	0.000271	0.00358	CcSEcCtD
Acetylsalicylic acid—Dizziness—Procarbazine—brain cancer	0.00027	0.00358	CcSEcCtD
Acetylsalicylic acid—Chest pain—Carmustine—brain cancer	0.000267	0.00353	CcSEcCtD
Acetylsalicylic acid—Convulsion—Temozolomide—brain cancer	0.000262	0.00347	CcSEcCtD
Acetylsalicylic acid—Hypertension—Temozolomide—brain cancer	0.000261	0.00346	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Hydroxyurea—brain cancer	0.000261	0.00345	CcSEcCtD
Acetylsalicylic acid—Vomiting—Procarbazine—brain cancer	0.00026	0.00344	CcSEcCtD
Acetylsalicylic acid—Flushing—Etoposide—brain cancer	0.000258	0.00342	CcSEcCtD
Acetylsalicylic acid—Confusional state—Carmustine—brain cancer	0.000258	0.00341	CcSEcCtD
Acetylsalicylic acid—Arthralgia—Temozolomide—brain cancer	0.000258	0.00341	CcSEcCtD
Acetylsalicylic acid—Rash—Procarbazine—brain cancer	0.000258	0.00341	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Procarbazine—brain cancer	0.000257	0.00341	CcSEcCtD
Acetylsalicylic acid—CYP2C8—pituitary gland—brain cancer	0.000254	0.00297	CbGeAlD
Acetylsalicylic acid—PTGS1—telencephalon—brain cancer	0.000253	0.00296	CbGeAlD
Acetylsalicylic acid—Thrombocytopenia—Carmustine—brain cancer	0.00025	0.00331	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Carmustine—brain cancer	0.00025	0.0033	CcSEcCtD
Acetylsalicylic acid—Confusional state—Temozolomide—brain cancer	0.000249	0.0033	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Temozolomide—brain cancer	0.000247	0.00327	CcSEcCtD
Acetylsalicylic acid—Nausea—Procarbazine—brain cancer	0.000243	0.00321	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Temozolomide—brain cancer	0.000242	0.0032	CcSEcCtD
Acetylsalicylic acid—PTGS2—telencephalon—brain cancer	0.000242	0.00283	CbGeAlD
Acetylsalicylic acid—Hyperhidrosis—Temozolomide—brain cancer	0.000239	0.00316	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Hydroxyurea—brain cancer	0.000233	0.00308	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Carmustine—brain cancer	0.000228	0.00302	CcSEcCtD
Acetylsalicylic acid—Somnolence—Carmustine—brain cancer	0.000227	0.00301	CcSEcCtD
Acetylsalicylic acid—CYP2C19—endocrine gland—brain cancer	0.000225	0.00264	CbGeAlD
Acetylsalicylic acid—Anaemia—Etoposide—brain cancer	0.000224	0.00296	CcSEcCtD
Acetylsalicylic acid—Dyspnoea—Temozolomide—brain cancer	0.00022	0.00292	CcSEcCtD
Acetylsalicylic acid—Somnolence—Temozolomide—brain cancer	0.00022	0.00291	CcSEcCtD
Acetylsalicylic acid—Vertigo—Etoposide—brain cancer	0.000218	0.00288	CcSEcCtD
Acetylsalicylic acid—Dyspepsia—Temozolomide—brain cancer	0.000218	0.00288	CcSEcCtD
Acetylsalicylic acid—Leukopenia—Etoposide—brain cancer	0.000217	0.00287	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Hydroxyurea—brain cancer	0.000216	0.00286	CcSEcCtD
Acetylsalicylic acid—Loss of consciousness—Etoposide—brain cancer	0.000213	0.00282	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Carmustine—brain cancer	0.000211	0.00279	CcSEcCtD
Acetylsalicylic acid—Convulsion—Etoposide—brain cancer	0.00021	0.00278	CcSEcCtD
Acetylsalicylic acid—Hypertension—Etoposide—brain cancer	0.000209	0.00277	CcSEcCtD
Acetylsalicylic acid—Dizziness—Hydroxyurea—brain cancer	0.000209	0.00277	CcSEcCtD
Acetylsalicylic acid—Chest pain—Etoposide—brain cancer	0.000206	0.00273	CcSEcCtD
Acetylsalicylic acid—PTGS1—pituitary gland—brain cancer	0.000206	0.00241	CbGeAlD
Acetylsalicylic acid—Feeling abnormal—Temozolomide—brain cancer	0.000204	0.0027	CcSEcCtD
Acetylsalicylic acid—Vomiting—Hydroxyurea—brain cancer	0.000201	0.00266	CcSEcCtD
Acetylsalicylic acid—ALB—brain—brain cancer	0.0002	0.00235	CbGeAlD
Acetylsalicylic acid—Rash—Hydroxyurea—brain cancer	0.000199	0.00264	CcSEcCtD
Acetylsalicylic acid—Confusional state—Etoposide—brain cancer	0.000199	0.00264	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Hydroxyurea—brain cancer	0.000199	0.00264	CcSEcCtD
Acetylsalicylic acid—Anaphylactic shock—Etoposide—brain cancer	0.000198	0.00262	CcSEcCtD
Acetylsalicylic acid—PTGS2—pituitary gland—brain cancer	0.000197	0.00231	CbGeAlD
Acetylsalicylic acid—CYP2C8—endocrine gland—brain cancer	0.000197	0.0023	CbGeAlD
Acetylsalicylic acid—Urticaria—Temozolomide—brain cancer	0.000196	0.0026	CcSEcCtD
Acetylsalicylic acid—Thrombocytopenia—Etoposide—brain cancer	0.000194	0.00256	CcSEcCtD
Acetylsalicylic acid—Tachycardia—Etoposide—brain cancer	0.000193	0.00255	CcSEcCtD
Acetylsalicylic acid—Hyperhidrosis—Etoposide—brain cancer	0.000191	0.00253	CcSEcCtD
Acetylsalicylic acid—PTGS2—medulla oblongata—brain cancer	0.00019	0.00223	CbGeAlD
Acetylsalicylic acid—Hypersensitivity—Carmustine—brain cancer	0.000188	0.00249	CcSEcCtD
Acetylsalicylic acid—Nausea—Hydroxyurea—brain cancer	0.000188	0.00249	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Temozolomide—brain cancer	0.000182	0.00241	CcSEcCtD
Acetylsalicylic acid—PTGS1—spinal cord—brain cancer	0.000177	0.00208	CbGeAlD
Acetylsalicylic acid—Dyspnoea—Etoposide—brain cancer	0.000176	0.00233	CcSEcCtD
Acetylsalicylic acid—Somnolence—Etoposide—brain cancer	0.000176	0.00233	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Carmustine—brain cancer	0.000175	0.00232	CcSEcCtD
Acetylsalicylic acid—Pruritus—Temozolomide—brain cancer	0.000175	0.00231	CcSEcCtD
Acetylsalicylic acid—CYP2C9—endocrine gland—brain cancer	0.000175	0.00205	CbGeAlD
Acetylsalicylic acid—PTGS2—midbrain—brain cancer	0.000173	0.00203	CbGeAlD
Acetylsalicylic acid—PTGS2—spinal cord—brain cancer	0.000169	0.00198	CbGeAlD
Acetylsalicylic acid—Dizziness—Carmustine—brain cancer	0.000169	0.00224	CcSEcCtD
Acetylsalicylic acid—Diarrhoea—Temozolomide—brain cancer	0.000169	0.00224	CcSEcCtD
Acetylsalicylic acid—Dizziness—Temozolomide—brain cancer	0.000163	0.00216	CcSEcCtD
Acetylsalicylic acid—Feeling abnormal—Etoposide—brain cancer	0.000163	0.00216	CcSEcCtD
Acetylsalicylic acid—Vomiting—Carmustine—brain cancer	0.000163	0.00215	CcSEcCtD
Acetylsalicylic acid—Rash—Carmustine—brain cancer	0.000161	0.00213	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Carmustine—brain cancer	0.000161	0.00213	CcSEcCtD
Acetylsalicylic acid—PTGS1—endocrine gland—brain cancer	0.000159	0.00187	CbGeAlD
Acetylsalicylic acid—PTGS1—head—brain cancer	0.000157	0.00185	CbGeAlD
Acetylsalicylic acid—Vomiting—Temozolomide—brain cancer	0.000157	0.00208	CcSEcCtD
Acetylsalicylic acid—Urticaria—Etoposide—brain cancer	0.000157	0.00208	CcSEcCtD
Acetylsalicylic acid—Rash—Temozolomide—brain cancer	0.000156	0.00206	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Temozolomide—brain cancer	0.000156	0.00206	CcSEcCtD
Acetylsalicylic acid—PTGS2—endocrine gland—brain cancer	0.000152	0.00179	CbGeAlD
Acetylsalicylic acid—Nausea—Carmustine—brain cancer	0.000152	0.00201	CcSEcCtD
Acetylsalicylic acid—PTGS2—head—brain cancer	0.00015	0.00176	CbGeAlD
Acetylsalicylic acid—ABCB1—telencephalon—brain cancer	0.000149	0.00175	CbGeAlD
Acetylsalicylic acid—Nausea—Temozolomide—brain cancer	0.000147	0.00194	CcSEcCtD
Acetylsalicylic acid—Hypersensitivity—Etoposide—brain cancer	0.000146	0.00193	CcSEcCtD
Acetylsalicylic acid—PTGS1—central nervous system—brain cancer	0.000144	0.00168	CbGeAlD
Acetylsalicylic acid—CYP2C8—brain—brain cancer	0.000141	0.00165	CbGeAlD
Acetylsalicylic acid—Pruritus—Etoposide—brain cancer	0.00014	0.00185	CcSEcCtD
Acetylsalicylic acid—PTGS2—central nervous system—brain cancer	0.000137	0.00161	CbGeAlD
Acetylsalicylic acid—Diarrhoea—Etoposide—brain cancer	0.000135	0.00179	CcSEcCtD
Acetylsalicylic acid—PTGS2—cerebellum—brain cancer	0.000134	0.00157	CbGeAlD
Acetylsalicylic acid—Dizziness—Etoposide—brain cancer	0.000131	0.00173	CcSEcCtD
Acetylsalicylic acid—Vomiting—Etoposide—brain cancer	0.000126	0.00166	CcSEcCtD
Acetylsalicylic acid—ABCB1—gonad—brain cancer	0.000125	0.00146	CbGeAlD
Acetylsalicylic acid—Rash—Etoposide—brain cancer	0.000125	0.00165	CcSEcCtD
Acetylsalicylic acid—Dermatitis—Etoposide—brain cancer	0.000125	0.00165	CcSEcCtD
Acetylsalicylic acid—ABCB1—pituitary gland—brain cancer	0.000122	0.00143	CbGeAlD
Acetylsalicylic acid—Nausea—Etoposide—brain cancer	0.000117	0.00155	CcSEcCtD
Acetylsalicylic acid—ABCB1—medulla oblongata—brain cancer	0.000117	0.00138	CbGeAlD
Acetylsalicylic acid—PTGS1—brain—brain cancer	0.000114	0.00134	CbGeAlD
Acetylsalicylic acid—PTGS2—brain—brain cancer	0.000109	0.00128	CbGeAlD
Acetylsalicylic acid—ABCB1—midbrain—brain cancer	0.000107	0.00126	CbGeAlD
Acetylsalicylic acid—ABCB1—spinal cord—brain cancer	0.000105	0.00123	CbGeAlD
Acetylsalicylic acid—ABCB1—endocrine gland—brain cancer	9.42e-05	0.0011	CbGeAlD
Acetylsalicylic acid—ABCB1—head—brain cancer	9.3e-05	0.00109	CbGeAlD
Acetylsalicylic acid—ABCB1—central nervous system—brain cancer	8.49e-05	0.000996	CbGeAlD
Acetylsalicylic acid—ABCB1—cerebellum—brain cancer	8.3e-05	0.000973	CbGeAlD
Acetylsalicylic acid—ABCB1—brain—brain cancer	6.74e-05	0.000791	CbGeAlD
Acetylsalicylic acid—IKBKB—B Cell Activation—EGFR—brain cancer	1.9e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—PIK3CG—brain cancer	1.9e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—PIK3CG—brain cancer	1.9e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—MYC—brain cancer	1.9e-05	0.000134	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Metabolism—PIK3CG—brain cancer	1.88e-05	0.000132	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—IL2—brain cancer	1.86e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—EGFR—brain cancer	1.86e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—NOTCH2—brain cancer	1.86e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—NOTCH2—brain cancer	1.86e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ABR—brain cancer	1.85e-05	0.000131	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—PDGFRA—brain cancer	1.84e-05	0.000129	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TRPC6—brain cancer	1.83e-05	0.000129	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.82e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—HSPA5—Immune System—EGFR—brain cancer	1.82e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Developmental Biology—EGFR—brain cancer	1.82e-05	0.000128	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—MAPK Signaling Pathway—TP53—brain cancer	1.8e-05	0.000127	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Innate Immune System—EGFR—brain cancer	1.8e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GLI2—brain cancer	1.79e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.79e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—SKP2—brain cancer	1.79e-05	0.000126	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IRS2—brain cancer	1.78e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VAV1—brain cancer	1.77e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VAV1—brain cancer	1.77e-05	0.000125	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.77e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—BSG—brain cancer	1.76e-05	0.000124	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—ERBB2—brain cancer	1.74e-05	0.000123	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Adaptive Immune System—EGFR—brain cancer	1.72e-05	0.000121	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—HES1—brain cancer	1.7e-05	0.00012	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	1.69e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GLI1—brain cancer	1.68e-05	0.000119	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—HES1—brain cancer	1.68e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—IRS2—brain cancer	1.68e-05	0.000118	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.66e-05	0.000117	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—CYP2C9—brain cancer	1.65e-05	0.000116	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PDGFRA—brain cancer	1.62e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—IRS2—brain cancer	1.61e-05	0.000114	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.61e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Innate Immune System—EGFR—brain cancer	1.61e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PDGFRA—brain cancer	1.6e-05	0.000113	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SUFU—brain cancer	1.6e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.59e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	1.58e-05	0.000112	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—SPP1—brain cancer	1.57e-05	0.000111	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—APC—brain cancer	1.57e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—PIK3CG—brain cancer	1.57e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Cytokine Signaling in Immune system—STAT3—brain cancer	1.57e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Spinal Cord Injury—TP53—brain cancer	1.56e-05	0.00011	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—SPP1—brain cancer	1.55e-05	0.000109	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—GFAP—brain cancer	1.54e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—STAT3—brain cancer	1.54e-05	0.000108	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—CTNNB1—brain cancer	1.52e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—HES1—brain cancer	1.52e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—HES1—brain cancer	1.52e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—RELA—brain cancer	1.52e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—IDH1—brain cancer	1.52e-05	0.000107	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—ERBB2—brain cancer	1.51e-05	0.000106	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—GPCR downstream signaling—IL2—brain cancer	1.47e-05	0.000104	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HEY1—brain cancer	1.46e-05	0.000103	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PDGFRA—brain cancer	1.45e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PDGFRA—brain cancer	1.45e-05	0.000102	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IDH1—brain cancer	1.44e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—DLL1—brain cancer	1.43e-05	0.000101	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IRS2—brain cancer	1.42e-05	0.0001	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—SPP1—brain cancer	1.41e-05	9.9e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—SPP1—brain cancer	1.41e-05	9.9e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IRS2—brain cancer	1.41e-05	9.9e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.4e-05	9.88e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling by NGF—EGFR—brain cancer	1.4e-05	9.85e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—BSG—brain cancer	1.4e-05	9.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.39e-05	9.77e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VAV1—brain cancer	1.37e-05	9.66e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—IL2—brain cancer	1.37e-05	9.63e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HEY1—brain cancer	1.36e-05	9.59e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—VAV1—brain cancer	1.36e-05	9.58e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—RELA—brain cancer	1.36e-05	9.56e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—ERBB2—brain cancer	1.35e-05	9.5e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—CYP2C9—brain cancer	1.34e-05	9.43e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—IL2—brain cancer	1.34e-05	9.42e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—IL2—brain cancer	1.34e-05	9.42e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—DLL1—brain cancer	1.34e-05	9.41e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—CYP2C9—brain cancer	1.33e-05	9.38e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—STAT3—brain cancer	1.33e-05	9.34e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—CTNNB1—brain cancer	1.32e-05	9.3e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.29e-05	9.09e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	1.29e-05	9.09e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IRS2—brain cancer	1.27e-05	8.95e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IRS2—brain cancer	1.27e-05	8.95e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	1.26e-05	8.89e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—APC—brain cancer	1.26e-05	8.85e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—PIK3CG—brain cancer	1.26e-05	8.85e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—APC—brain cancer	1.24e-05	8.74e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—PIK3CG—brain cancer	1.24e-05	8.74e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.23e-05	8.69e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—MYC—brain cancer	1.23e-05	8.68e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—RELA—brain cancer	1.23e-05	8.63e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—IL2—brain cancer	1.22e-05	8.61e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—ERBB2—brain cancer	1.22e-05	8.58e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SHH—brain cancer	1.22e-05	8.57e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Disease—EGFR—brain cancer	1.21e-05	8.49e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—IDH1—brain cancer	1.2e-05	8.47e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—ENO2—brain cancer	1.2e-05	8.44e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—CYP2C9—brain cancer	1.2e-05	8.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	1.19e-05	8.37e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—CTNNB1—brain cancer	1.18e-05	8.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TRPC6—brain cancer	1.17e-05	8.27e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—CYP2C9—brain cancer	1.17e-05	8.21e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—RELA—brain cancer	1.16e-05	8.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PTCH1—brain cancer	1.15e-05	8.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SMO—brain cancer	1.15e-05	8.13e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—ERBB2—brain cancer	1.15e-05	8.11e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—STAT3—brain cancer	1.15e-05	8.1e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.14e-05	8.03e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—BSG—brain cancer	1.14e-05	8.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ENO2—brain cancer	1.14e-05	8e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—SHH—brain cancer	1.14e-05	8e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—BSG—brain cancer	1.13e-05	7.97e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.13e-05	7.96e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—APC—brain cancer	1.12e-05	7.91e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—APC—brain cancer	1.12e-05	7.91e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—PIK3CG—brain cancer	1.12e-05	7.91e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—PIK3CG—brain cancer	1.12e-05	7.91e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—PDGFRA—brain cancer	1.11e-05	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—RELA—brain cancer	1.11e-05	7.84e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—ERBB2—brain cancer	1.11e-05	7.79e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—IL2—brain cancer	1.1e-05	7.78e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CCND1—brain cancer	1.08e-05	7.58e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—CTNNB1—brain cancer	1.07e-05	7.51e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	1.06e-05	7.47e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Immune System—EGFR—brain cancer	1.05e-05	7.36e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—STAT3—brain cancer	1.03e-05	7.24e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling by GPCR—EGFR—brain cancer	1.02e-05	7.2e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling by GPCR—EGFR—brain cancer	1.02e-05	7.2e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—BSG—brain cancer	1.02e-05	7.16e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	1.01e-05	7.11e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—CTNNB1—brain cancer	1.01e-05	7.09e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.95e-06	7e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—BSG—brain cancer	9.92e-06	6.98e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—RELA—brain cancer	9.82e-06	6.91e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	9.8e-06	6.9e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—IDH1—brain cancer	9.79e-06	6.89e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IRS2—brain cancer	9.78e-06	6.89e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—ERBB2—brain cancer	9.76e-06	6.87e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—IDH1—brain cancer	9.74e-06	6.86e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—RELA—brain cancer	9.7e-06	6.83e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—ERBB2—brain cancer	9.64e-06	6.79e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—ENO2—brain cancer	9.51e-06	6.7e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—VEGFA—brain cancer	9.39e-06	6.61e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Immune System—EGFR—brain cancer	9.35e-06	6.58e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—STAT3—brain cancer	9.29e-06	6.54e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—BSG—brain cancer	9.27e-06	6.53e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—NOTCH2—brain cancer	9.23e-06	6.5e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	9.15e-06	6.44e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.95e-06	6.3e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—IL2—brain cancer	8.84e-06	6.23e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VAV1—brain cancer	8.8e-06	6.19e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—RELA—brain cancer	8.78e-06	6.18e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—RELA—brain cancer	8.78e-06	6.18e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—IDH1—brain cancer	8.74e-06	6.15e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—IL2—brain cancer	8.74e-06	6.15e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—ERBB2—brain cancer	8.72e-06	6.14e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—ERBB2—brain cancer	8.72e-06	6.14e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—PIK3CG—brain cancer	8.71e-06	6.13e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—MYC—brain cancer	8.64e-06	6.08e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CCND1—brain cancer	8.62e-06	6.07e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—CTNNB1—brain cancer	8.54e-06	6.01e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—IDH1—brain cancer	8.53e-06	6.01e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CCND1—brain cancer	8.52e-06	6e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—EGFR—brain cancer	8.45e-06	5.95e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—CTNNB1—brain cancer	8.44e-06	5.94e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—VAV1—brain cancer	8.21e-06	5.78e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Innate Immune System—EGFR—brain cancer	7.98e-06	5.62e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.97e-06	5.61e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—IDH1—brain cancer	7.97e-06	5.61e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.93e-06	5.58e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—IL2—brain cancer	7.9e-06	5.56e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—IL2—brain cancer	7.9e-06	5.56e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—ENO2—brain cancer	7.74e-06	5.45e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CCND1—brain cancer	7.7e-06	5.42e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CCND1—brain cancer	7.7e-06	5.42e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—ENO2—brain cancer	7.7e-06	5.42e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Adaptive Immune System—EGFR—brain cancer	7.67e-06	5.4e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—CTNNB1—brain cancer	7.63e-06	5.37e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—CTNNB1—brain cancer	7.63e-06	5.37e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—HES1—brain cancer	7.57e-06	5.33e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.52e-06	5.29e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—VEGFA—brain cancer	7.51e-06	5.29e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—STAT3—brain cancer	7.44e-06	5.24e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—VEGFA—brain cancer	7.43e-06	5.23e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—STAT3—brain cancer	7.35e-06	5.18e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PDGFRA—brain cancer	7.2e-06	5.07e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.12e-06	5.01e-05	CbGpPWpGaD
Acetylsalicylic acid—AKR1C1—Signaling Pathways—TP53—brain cancer	7.09e-06	4.99e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—HES1—brain cancer	7.06e-06	4.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—SPP1—brain cancer	6.99e-06	4.92e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—MYC—brain cancer	6.91e-06	4.87e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—ENO2—brain cancer	6.91e-06	4.86e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—MYC—brain cancer	6.83e-06	4.81e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—EGFR—brain cancer	6.76e-06	4.76e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—RELA—brain cancer	6.75e-06	4.75e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—ENO2—brain cancer	6.74e-06	4.75e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—PDGFRA—brain cancer	6.72e-06	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—VEGFA—brain cancer	6.72e-06	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—VEGFA—brain cancer	6.72e-06	4.73e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—ERBB2—brain cancer	6.71e-06	4.72e-05	CbGpPWpGaD
Acetylsalicylic acid—TP53—Signaling Pathways—EGFR—brain cancer	6.68e-06	4.71e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—STAT3—brain cancer	6.65e-06	4.68e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—STAT3—brain cancer	6.65e-06	4.68e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.49e-06	4.57e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IRS2—brain cancer	6.32e-06	4.45e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—ENO2—brain cancer	6.3e-06	4.44e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—MYC—brain cancer	6.18e-06	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—MYC—brain cancer	6.18e-06	4.35e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—IL2—brain cancer	6.13e-06	4.31e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—IL2—brain cancer	6.08e-06	4.28e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—EGFR—brain cancer	6.04e-06	4.26e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—EGFR—brain cancer	6.04e-06	4.26e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—IRS2—brain cancer	5.9e-06	4.15e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—CTNNB1—brain cancer	5.87e-06	4.13e-05	CbGpPWpGaD
Acetylsalicylic acid—NFKBIA—Signaling Pathways—TP53—brain cancer	5.68e-06	4e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—PIK3CG—brain cancer	5.59e-06	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—APC—brain cancer	5.59e-06	3.93e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS1—Metabolism—PIK3CG—brain cancer	5.5e-06	3.87e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—APC—brain cancer	5.21e-06	3.67e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—VEGFA—brain cancer	5.21e-06	3.67e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—STAT3—brain cancer	5.12e-06	3.6e-05	CbGpPWpGaD
Acetylsalicylic acid—RPS6KA3—Signaling Pathways—TP53—brain cancer	5.08e-06	3.57e-05	CbGpPWpGaD
Acetylsalicylic acid—EDNRA—Signaling Pathways—TP53—brain cancer	5.08e-06	3.57e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Immune System—EGFR—brain cancer	4.65e-06	3.27e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—RELA—brain cancer	4.36e-06	3.07e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Metabolism—PIK3CG—brain cancer	4.36e-06	3.07e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—ERBB2—brain cancer	4.34e-06	3.05e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—ERBB2—brain cancer	4.05e-06	2.85e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Hemostasis—TP53—brain cancer	3.93e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—IL2—brain cancer	3.93e-06	2.77e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CCND1—brain cancer	3.83e-06	2.7e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—CTNNB1—brain cancer	3.79e-06	2.67e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C8—Metabolism—PIK3CG—brain cancer	3.55e-06	2.5e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—CTNNB1—brain cancer	3.54e-06	2.49e-05	CbGpPWpGaD
Acetylsalicylic acid—ALB—Metabolism—PIK3CG—brain cancer	3.53e-06	2.49e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—VEGFA—brain cancer	3.34e-06	2.35e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—STAT3—brain cancer	3.31e-06	2.33e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C19—Metabolism—PIK3CG—brain cancer	3.17e-06	2.23e-05	CbGpPWpGaD
Acetylsalicylic acid—ABCB1—Metabolism—PIK3CG—brain cancer	3.09e-06	2.18e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—STAT3—brain cancer	3.09e-06	2.17e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—MYC—brain cancer	3.07e-06	2.16e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—EGFR—brain cancer	3.01e-06	2.12e-05	CbGpPWpGaD
Acetylsalicylic acid—CYP2C9—Metabolism—PIK3CG—brain cancer	2.89e-06	2.03e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—MYC—brain cancer	2.87e-06	2.02e-05	CbGpPWpGaD
Acetylsalicylic acid—PTGS2—Disease—EGFR—brain cancer	2.8e-06	1.97e-05	CbGpPWpGaD
Acetylsalicylic acid—IKBKB—Signaling Pathways—TP53—brain cancer	2.52e-06	1.78e-05	CbGpPWpGaD
